Sep 2026· Frontiers in Cellular and Infection Microbiology· Vol 16· 0 citations· 277 references
Medicine
Abstract
The rapid emergence of global antimicrobial resistance (AMR) has outpaced the development of new antimicrobial agents, necessitating transformative approaches such as AI-driven in-silico drug discovery. Antimicrobial peptides (AMPs) are promising alternatives due to their broad-spectrum bactericidal activity and limited susceptibility to resistance. However, the transition from bench to bedside remains constrained by certain challenges, such as instability, potency, and cytotoxicity. Here, well-integrated, multi-model AI-driven pipeline strategies for the mining and discovery of novel AMPs are designed to address these concerns through simultaneous multi-purpose optimization. The proposed architectural frameworks combine discriminative AMP classifiers, quantitative potency, and cytotoxicity screening filters to prioritize AMPs with good efficacy and safety profiles. To ensure novelty, the pipeline integrates multi-layer sequential and genomic screening by adopting alignment and profile-based approaches. Structural refinements are achieved through advanced molecular docking (MD) and protein folding approaches, providing mechanistic insights regarding peptide–target interactions. In parallel, enzymatic susceptibility and stability prediction models are incorporated to optimize AMP pharmacokinetic potentials. Notably, the multi-objective pipeline operates within iterative optimization loops; discriminative and generative AI models and sequential redesign strategies refine candidates based on multi-purpose closed feedback loops across stability, novelty, efficacy, and toxicity outcomes. These systematic and integrated approaches overcome key bottlenecks associated with traditional linear drug discovery, potentially reducing late-stage attrition and accelerating the transformation from in-silico predictions to wet-lab validation. Collectively, this review provides reproducible and generalizable blueprints for next-generation antimicrobial agents, demonstrating the computational potentials of AI-driven, multi-model architectural frameworks to tackle the global AMR crisis and favour precision design of AMPs with better therapeutic indices.
The generation-screening-validation workflow enables reliable discovery of potent AMPs, and provides a practical strategy for rational peptide design, rapid prediction, and translational applications.
This review synthesizes recent advances in AMP research, focusing on their structural diversity, mechanistic interactions with microbial membranes, and immunomodulatory roles in shaping host-microbe dynamics, and establishes a framework for overcoming current limitations.
Wasim Ullah Khan, Zhu-Yu Hua, Xu Xia et al.· Frontiers in Microbiology· 0 citations
Global aquaculture faces an escalating disease and antimicrobial resistance (AMR) crisis, exacerbated by climate-driven physiochemical shifts and intensive farming practices. The integration of artificial intelligence (AI) and structural biology, spearheaded by AlphaFold, represents a paradigm shift in aquatic pharmaco...
Enes Üstüner, Mustafa Öz· Biotechnology and Bioenginee...· 0 citations
The developed XAI framework, together with the pathogen-specific predictive models, the pathogen-selective fragment lists, and their mapping onto the chemical structures, is able to provide a highly valuable and practical guide to the rational design of new antimicrobial agents.
Abdulmujeeb T. Onawole, M. Blaskovich, Johannes Zuegg· ACS Infectious Diseases· 0 citations
This study provides an experimental assessment of model-guided AMP discovery and a reproducible route from computational prediction to validated antimicrobial candidates, while revealing biases and generalizability limits of AI-based AMP inference.
S. Ojeda, P. Ávila, S. Castellanos et al.· bioRxiv· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduNov 9, 2026
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.